Oncology Market Access 2011 is a conference that covers topics such as:
Succeed in pricing negotiations and effective market access strategy
The uncertainty in current pricing, increasing complexity and reimbursement environment in order to "Unlock" the Oncology Market Access 2011 across Europe
Cost-effectiveness measures & the impact on the industry
Early patient access to new cancer drugs and the need for benefit/risk data
Market access as part of the entire drug’s life cycle
Market access as an integral part of the pharma company
The role of HTAs
New market access model?
Healthcare & hospital budgets challenges
Funding of new cancer drugs
The concept of risk-sharing
Oncology Market Access brings together executives and Managers from the pharmaceutical industry that are involved in Market Access, Oncology, Health Economics & Outcomes Research, Pricing & Reimbursement, Medical affairs, Oncology Marketing, Public Affairs, Governmental Affairs, Country Managers, Therapeutic Area Heads, Government bodies, HTA agencies and Regulatory Bodies.
